Viatris | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
Adcock Ingram Holdings ZAR 5.54B 131.19M 2024-12
Celltrion KRW 17.14T 298.25B 2025-03
Cspc Pharmaceutical CNY 32.26B 2.59B 2024-12
Dianthus Therapeutics USD 352.48M 14.58M 2024-12
Divis Laboratories Ltd 149.69B 12.52B 2025-03
Kangmei Pharma CNY 7.18B 8.52M 2025-03
Knight Therapeutics CAD 773.91M 11.11M 2024-09
Laboratorios Farma EUR 581.54M 98.78M 2024-12
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 55.33M 9.6M 2024-12
Neuren Pharmaceuticals AUD 363.9M 144.75M 2024-12
Organigram Holdings CAD 323.65M 17.66M 2024-12
Pharma Mar EUR 201.53M 4.06M 2025-06
Qiagen NV USD 3.51B 97.61M 2025-06
Sartorius EUR 2.66B 51.3M 2025-06
Sino Biopharmaceutical CNY 31.96B 884.2M 2024-12
Tilray USD 3.47B 5.16M 2024-11
Viatris USD 15.57B 79.9M 2025-06
Zz Pientze Pharmaceu 15.26B 991.2M 2025-03


Viatris Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.